These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
30. Methods for the reduction of transfusion-transmitted cytomegalovirus infection: filtration versus the use of seronegative donor units. Hillyer CD; Emmens RK; Zago-Novaretti M; Berkman EM Transfusion; 1994 Oct; 34(10):929-34. PubMed ID: 7940668 [No Abstract] [Full Text] [Related]
31. Limited efficacy of universal leucodepletion in reducing the incidence of febrile nonhaemolytic reactions in red cell transfusions. Ibojie J; Greiss MA; Urbaniak SJ Transfus Med; 2002 Jun; 12(3):181-5. PubMed ID: 12071874 [TBL] [Abstract][Full Text] [Related]
32. Prevention of transfusion-acquired cytomegalovirus infection in infants by blood filtration to remove leucocytes. Neonatal Cytomegalovirus Infection Study Group. Gilbert GL; Hayes K; Hudson IL; James J Lancet; 1989 Jun; 1(8649):1228-31. PubMed ID: 2566781 [TBL] [Abstract][Full Text] [Related]
33. Isolation of human cytomegalovirus from the circulating leucocytes of a leukaemic patient. Jack I; Todd H; Turner EK Med J Aust; 1968 Feb; 1(6):210-3. PubMed ID: 4295969 [No Abstract] [Full Text] [Related]
34. Cytomegalovirus infections associated with leukocyte transfusions. Winston DJ; Ho WG; Howell CL; Miller MJ; Mickey R; Martin WJ; Lin CH; Gale RP Ann Intern Med; 1980 Nov; 93(5):671-5. PubMed ID: 6259981 [TBL] [Abstract][Full Text] [Related]
35. The role of UV radiation in the prevention of human leukocyte antigen alloimmunization. Andreu G; Boccaccio C; Klaren J; Lecrubier C; Pirenne F; Garcia I; Baudard M; Devers L; Fournel JJ Transfus Med Rev; 1992 Jul; 6(3):212-24. PubMed ID: 1498466 [No Abstract] [Full Text] [Related]
36. Prevention of transfusion-associated cytomegalovirus infection: defining the method of preparation for leukocyte-reduced blood products. Dumont LJ; Schuyler R Blood; 1996 Aug; 88(4):1515. PubMed ID: 8695874 [No Abstract] [Full Text] [Related]
37. A very simple and nonexpensive technique to prevent febrile nonhemolytic transfusion reactions in HLA-immunized patients. Matthieu F Vox Sang; 1995; 68(3):201-2. PubMed ID: 7625081 [No Abstract] [Full Text] [Related]
38. Alloimmunization after leukocyte-depleted multiple random donor platelet transfusions. Brand A; Claas FH; Voogt PJ; Wasser MN; Eernisse JG Vox Sang; 1988; 54(3):160-6. PubMed ID: 3369136 [TBL] [Abstract][Full Text] [Related]
39. [Post-transfusional cytomegalovirus infections: incidence and methods of prevention. CMV group of SNTS]. Andreu G; Marinière AM; Fretz C; Emile JF; Bierling P; Brossard Y; Girard M; Gluckman E; Huart JJ; Janot C Rev Fr Transfus Hemobiol; 1991 May; 34(3):213-32. PubMed ID: 1648357 [No Abstract] [Full Text] [Related]
40. An overview of laboratory and clinical aspects of leucocyte-depleted blood components. Seghatchian MJ Transfus Sci; 1994 Mar; 15(1):49-56. PubMed ID: 10147198 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]